Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
16
Number of overlapping holdings
28.1%
% of HELX's 68 holdings also in GNOM
39.0%
% of GNOM's 41 holdings also in HELX
Overlap by Weight
Sector Drift (HELX minus GNOM)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in HELX |
Weight in GNOM |
Overlap | |
|---|---|---|---|---|
 |
AGILENT TECHNOLOGIES INC | 2.1% | 4.3% | 2.1% |
 |
BIONTECH SE SPONSORED ADR | 1.9% | 2.9% | 1.9% |
|
QIAGEN NV | 1.9% | 3.3% | 1.9% |
|
VERTEX PHARMACEUTICALS INC | 4.8% | 1.7% | 1.7% |
|
MODERNA, INC. | 1.7% | 4.1% | 1.7% |
Position Highlights (Non-Overlapping Exposures)
HELX Overweight Relative to GNOM
|
MEDPACE HOLDINGS, INC. | 8.0% |
|
THERMO FISHER SCIENTIFIC INC | 6.2% |
|
DANAHER CORP | 5.4% |
|
REGENERON PHARMACEUTICALS | 4.6% |
|
ELI LILLY & CO | 4.2% |
|
KRYSTAL BIOTECH, INC. | 3.7% |
|
BRUKER CORP | 3.2% |
|
SARTORIUS AG PREF | 3.1% |
|
VERTEX PHARMACEUTICALS INC | 3.1% |
 |
SAMSUNG BIOLOGICS CO., LTD. | 2.9% |
HELX Underweight Relative to GNOM
 |
ENI SPA-SPONSORED ADR | -7.2% |
|
NATERA INC | -6.6% |
|
ULTRAGENYX PHARMACEUTICAL IN | -4.7% |
|
CRISPR THERAPEUTICS AG | -4.1% |
|
ILLUMINA INC | -3.5% |
|
ARROWHEAD PHARMACEUTICALS, INC. | -3.3% |
|
BIOMARIN PHARMACEUTICAL INC | -3.3% |
|
AVIDITY BIOSCIENCES INC | -3.0% |
|
10X GENOMICS INC CLASS A | -2.9% |
|
MYRIAD GENETICS INC | -2.7% |